Related Experiment Video
Updated: Aug 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Possible pseudoresistance of Streptococcus pneumoniae to penicillin G in a patient with a mixed
Abstract:
We report the case of a 53-year-old woman with a mixed pneumococcus-staphylococcus pneumonia, in which both organisms were recovered from both sputum and blood. Streptococcus pneumoniae persisted in sputum 48 hours after initiation of high-dose intravenous penicillin G. When nafcillin was substituted for penicillin G, both pneumococci and staphylococci were eradicated from blood and sputum. This strain of Streptococcus pneumoniae was highly susceptible to penicillin G, but the associated strain of Staphylococcus aureus was not. The staphylococcus produced large amounts of a penicillin -degrading betalactamase . We reviewed the records of ten cases of pneumococcus pneumonia from the Wayne State University-Detroit Medical Center admitted from March 1978 to April 1981, in which sputum cultures were repeated within one to ten days after penicillin G had been initiated. At second cultures of sputum, Streptococcus pneumoniae was recovered in none of these latter cases. We further showed that on a blood agar culture plate in the presence of penicillin G, a beta-lactamase positive strain of Staphylococcus aureus allowed growth of Streptococcus pneumoniae. Therefore, despite penicillin therapy, Staphylococcus aureus in sputum may facilitate the persistence of Streptococcus pneumoniae.
Insights
In mixed pneumococcus-staphylococcus pneumonia, Staphylococcus aureus may hinder penicillin treatment by producing betalactamase. This can lead to persistent Streptococcus pneumoniae infections even with appropriate penicillin G therapy.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Pneumonia is a common respiratory infection, often caused by bacteria like Streptococcus pneumoniae.
- Mixed bacterial infections, involving multiple pathogens, can complicate treatment and patient outcomes.
Observation:
- A case of mixed Streptococcus pneumoniae and Staphylococcus aureus pneumonia is presented.
- Streptococcus pneumoniae persisted in sputum despite high-dose intravenous penicillin G therapy.
Findings:
- The Staphylococcus aureus strain produced betalactamase, an enzyme that degrades penicillin.
- Substitution of penicillin G with nafcillin eradicated both bacterial species.
- In vitro, Staphylococcus aureus facilitated Streptococcus pneumoniae growth in the presence of penicillin G.
Implications:
- Staphylococcus aureus betalactamase production can lead to treatment failure in mixed pneumococcal pneumonia.
- This highlights the importance of identifying co-infections and antibiotic resistance mechanisms.
- Antimicrobial stewardship must consider potential drug-inactivating interactions between co-infecting bacteria.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction

